Phenolic compounds as natural and multifunctional anti-obesity agents: A review

Celia Rodríguez-Pérez1, Antonio Segura-Carretero1, María Del Mar Contreras2

  • 1a Department of Analytical Chemistry , Faculty of Sciences, University of Granada , Avenida Fuentenueva s/n, Granada , Spain.

Insights

Phenolic compounds show promise in managing obesity by influencing appetite, fat metabolism, and inflammation. This review explores their anti-obesity effects from various plant sources.

Area of Science:

  • Nutritional Science
  • Biochemistry
  • Pharmacology

Background:

  • Obesity is a global health crisis with increasing prevalence.
  • Phenolic compounds are increasingly recognized for their potential role in obesity management.
  • Existing in vitro and in vivo studies suggest multiple mechanisms of action for phenolics.

Purpose of the Study:

  • To review recent evidence on the anti-obesity effects of phenolic compounds.
  • To synthesize findings from in vitro, in vivo, and clinical studies.
  • To focus on popular plant-based sources like cocoa, cinnamon, olive oil, red wine, and teas.

Main Methods:

  • Literature review of in vitro, in vivo, and clinical studies.
  • Analysis of research on phenolic compounds from various plant-based foods and beverages.
  • Focus on mechanisms such as appetite regulation, lipogenesis, lipolysis, and oxidative stress.

Main Results:

  • Phenolic compounds demonstrate potential in lowering food intake and decreasing lipogenesis.
  • Evidence suggests increased lipolysis and enhanced fatty acid beta-oxidation.
  • Phenolics inhibit adipocyte differentiation, reduce inflammation, and suppress oxidative stress.

Conclusions:

  • Phenolic compounds from diverse plant sources offer a promising strategy for obesity management.
  • Further clinical studies are warranted to confirm efficacy and optimal dosage.
  • Incorporating phenolic-rich foods and beverages may contribute to weight management strategies.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
199
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
615
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.9K